{Reference Type}: Journal Article
{Title}: Leydig and Sertoli cell function in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion: a case-control study.
{Author}: Guaragna-Filho G;Calixto AR;Astur ABLDV;Paula GB;Oliveira LC;Morcillo AM;Gonçalves EM;Mello MP;Maciel-Guerra AT;Guerra-Junior G;Guaragna-Filho G;Calixto AR;Astur ABLDV;Paula GB;Oliveira LC;Morcillo AM;Gonçalves EM;Mello MP;Maciel-Guerra AT;Guerra-Junior G;Guaragna-Filho G;Calixto AR;Astur ABLDV;Paula GB;Oliveira LC;Morcillo AM;Gonçalves EM;Mello MP;Maciel-Guerra AT;Guerra-Junior G;Guaragna-Filho G;Calixto AR;Astur ABLDV;Paula GB;Oliveira LC;Morcillo AM;Gonçalves EM;Mello MP;Maciel-Guerra AT;Guerra-Junior G;
{Journal}: Sao Paulo Med J
{Volume}: 140
{Issue}: 2
{Year}: Mar-Apr 2022
{Factor}: 1.838
{DOI}: 10.1590/1516-3180.2021.0042.R1.08062021
{Abstract}: <B>BACKGROUND: </B>Because normal male sexual differentiation is more complex than normal female sexual differentiation, there are more cases of disorders of sex development (DSDs) with 46,XY karyotype that have unclear etiology. However, Leydig and Sertoli cell markers are rarely used in distinguishing such individuals.<BR><B>OBJECTIVE: </B>To evaluate the function of Leydig and Sertoli cells in individuals with genital ambiguity, 46,XY karyotype, palpable gonads and normal testosterone secretion.<BR><B>METHODS: </B>Case-control study with 77 patients, including eight with partial androgen insensitivity syndrome, eight with 5α-reductase deficiency type 2 (5ARD2) and 19 with idiopathic 46,XY DSD, and 42 healthy controls, from the Interdisciplinary Study Group for Sex Determination and Differentiation (GIEDDS), at the State University of Campinas (UNICAMP), Campinas, Brazil.<BR><B>METHODS: </B>Baseline levels of gonadotropins, anti-Müllerian hormone (AMH), inhibin B, insulin-like 3 (INSL3), testosterone and dihydrotestosterone in cases, and AMH, inhibin B, and INSL3 levels in controls, were assessed.<BR><B>RESULTS: </B>There was no significant difference in age between cases and controls (P = 0.595). AMH and inhibin B levels were significantly lower in cases than in controls (P = 0.031 and P < 0.001, respectively). INSL3 levels were significantly higher in cases than in controls (P = 0.003). Inhibin B levels were lower in 5ARD2 patients (P = 0.045) and idiopathic patients (P = 0.001), in separate comparisons with the controls.<BR><B>CONCLUSIONS: </B>According to our findings, we can speculate that inhibin B levels may be used to differentiate among DSD cases.